Xiangxue Pharmaceutical Co.,Ltd. (300147.SZ)
CNY 6.16
(5.12%)
CNY 6.16
(5.12%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 53.79 Million CNY | -117.55% |
| 2022 | -152.93 Million CNY | -537.13% |
| 2021 | 34.98 Million CNY | -89.33% |
| 2020 | 327.97 Million CNY | 19.17% |
| 2019 | 275.21 Million CNY | 118.38% |
| 2018 | 126.02 Million CNY | 19.4% |
| 2017 | 105.54 Million CNY | 78.26% |
| 2016 | 59.2 Million CNY | -68.09% |
| 2015 | 185.56 Million CNY | -10.33% |
| 2014 | 206.94 Million CNY | 16.7% |
| 2013 | 177.33 Million CNY | 41.09% |
| 2012 | 125.68 Million CNY | 29.32% |
| 2011 | 97.19 Million CNY | 11.92% |
| 2010 | 86.84 Million CNY | 44.48% |
| 2009 | 60.1 Million CNY | 70.18% |
| 2008 | 35.32 Million CNY | -1.28% |
| 2007 | 35.77 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -67.55 Million CNY | -305.03% |
| 2024 Q1 | -16.67 Million CNY | 92.85% |
| 2024 Q3 | -72.05 Million CNY | 36.19% |
| 2023 Q4 | -233.18 Million CNY | -296.39% |
| 2023 Q2 | -55.86 Million CNY | -468.53% |
| 2023 Q3 | -58.82 Million CNY | -5.3% |
| 2023 FY | -332.71 Million CNY | -117.55% |
| 2023 Q1 | 15.15 Million CNY | 106.48% |
| 2022 Q4 | -233.96 Million CNY | -1341.54% |
| 2022 FY | -152.93 Million CNY | -537.13% |
| 2022 Q1 | -24.27 Million CNY | 96.35% |
| 2022 Q3 | -16.22 Million CNY | 75.44% |
| 2022 Q2 | -66.08 Million CNY | -172.19% |
| 2021 FY | 34.98 Million CNY | -89.33% |
| 2021 Q4 | -665.75 Million CNY | -5717.27% |
| 2021 Q1 | 37.22 Million CNY | 28.25% |
| 2021 Q2 | 51.26 Million CNY | 37.7% |
| 2021 Q3 | -11.44 Million CNY | -122.33% |
| 2020 Q2 | 87.21 Million CNY | -3.01% |
| 2020 Q1 | 89.92 Million CNY | 1565.55% |
| 2020 Q4 | 29.02 Million CNY | 25.73% |
| 2020 FY | 327.97 Million CNY | 19.17% |
| 2020 Q3 | 23.08 Million CNY | -73.53% |
| 2019 Q2 | 26.37 Million CNY | -45.12% |
| 2019 Q1 | 48.05 Million CNY | 15.11% |
| 2019 FY | 275.21 Million CNY | 118.38% |
| 2019 Q4 | -6.13 Million CNY | -113.86% |
| 2019 Q3 | 44.27 Million CNY | 67.86% |
| 2018 Q1 | 13.98 Million CNY | -50.52% |
| 2018 FY | 126.02 Million CNY | 19.4% |
| 2018 Q2 | 13.87 Million CNY | -0.84% |
| 2018 Q3 | 56.41 Million CNY | 306.71% |
| 2018 Q4 | 41.74 Million CNY | -26.0% |
| 2017 Q4 | 28.27 Million CNY | 2.22% |
| 2017 Q1 | 2.5 Million CNY | 109.3% |
| 2017 FY | 105.54 Million CNY | 78.26% |
| 2017 Q2 | 47.11 Million CNY | 1784.16% |
| 2017 Q3 | 27.65 Million CNY | -41.3% |
| 2016 Q3 | 16.39 Million CNY | -52.38% |
| 2016 Q2 | 34.42 Million CNY | -2.43% |
| 2016 Q1 | 35.28 Million CNY | 44.93% |
| 2016 FY | 59.2 Million CNY | -68.09% |
| 2016 Q4 | -26.89 Million CNY | -264.03% |
| 2015 Q4 | 24.34 Million CNY | -55.13% |
| 2015 Q3 | 54.25 Million CNY | -9.67% |
| 2015 Q1 | 46.91 Million CNY | -0.34% |
| 2015 Q2 | 60.05 Million CNY | 28.02% |
| 2015 FY | 185.56 Million CNY | -10.33% |
| 2014 Q3 | 57.31 Million CNY | -5.13% |
| 2014 FY | 206.94 Million CNY | 16.7% |
| 2014 Q4 | 47.07 Million CNY | -17.86% |
| 2014 Q2 | 60.4 Million CNY | 43.33% |
| 2014 Q1 | 42.14 Million CNY | -21.45% |
| 2013 Q3 | 63.22 Million CNY | 79.82% |
| 2013 Q4 | 53.65 Million CNY | -15.13% |
| 2013 FY | 177.33 Million CNY | 41.09% |
| 2013 Q1 | 25.29 Million CNY | -19.96% |
| 2013 Q2 | 35.15 Million CNY | 38.97% |
| 2012 FY | 125.68 Million CNY | 29.32% |
| 2012 Q1 | 16.14 Million CNY | -47.11% |
| 2012 Q3 | 44.75 Million CNY | 34.85% |
| 2012 Q2 | 33.18 Million CNY | 105.6% |
| 2012 Q4 | 31.6 Million CNY | -29.37% |
| 2011 Q4 | 30.52 Million CNY | -10.64% |
| 2011 Q1 | 15.13 Million CNY | -47.35% |
| 2011 FY | 97.19 Million CNY | 11.92% |
| 2011 Q2 | 17.38 Million CNY | 14.89% |
| 2011 Q3 | 34.15 Million CNY | 96.47% |
| 2010 FY | 86.84 Million CNY | 44.48% |
| 2010 Q3 | 27.17 Million CNY | 38.02% |
| 2010 Q2 | 19.68 Million CNY | 75.08% |
| 2010 Q4 | 28.74 Million CNY | 5.79% |
| 2010 Q1 | 11.24 Million CNY | -39.53% |
| 2009 FY | 60.1 Million CNY | 70.18% |
| 2009 Q3 | 15.34 Million CNY | 0.0% |
| 2009 Q4 | 18.59 Million CNY | 21.19% |
| 2008 FY | 35.32 Million CNY | -1.28% |
| 2007 FY | 35.77 Million CNY | 0.0% |